Therapy related coagulopathies
Reviewer: Jeremy Parsons, M.D. (see Reviewers page)
Revised: 13 June 2012, last major update June 2012
Copyright: (c) 2002-2012, PathologyOutlines.com, Inc.
● Used to treat myocardial infarction, pulmonary embolism, arterial or venous thrombosis, thrombotic stroke
● Thrombolytic agents include recombinant t-PA, urokinase, streptokinase (only tPA is widely available in the USA)
● Presence of fibrin degradation products and D-dimers, decreased fibrinogen and plasminogen, prolonged thrombin time, PT and PTT
● Clin Lab Med 2009;29:159
End of Coagulation > Therapy related coagulopathies > Thrombolytic therapy
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).